Der „Lazarus-Bericht“
Die Untersuchung des Meldeverhaltens bei unerwünschten Nebenwirkungen von Impfungen aus den Jahren 2007-9 vom Harvard Pilgrim Health Care unter Leitung von Prof. Ross Lazarus, Epidemiologe, Harvard Medical School, Boston
„Adverse events from drugs and vaccines are common, but underreported. Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA).
Likewise, fewer than 1% of vaccine adverse events are reported. Low reporting rates preclude or slow the identification of “problem” drugs and vaccines that endanger public health.“
Likewise, fewer than 1% of vaccine adverse events are reported. Low reporting rates preclude or slow the identification of “problem” drugs and vaccines that endanger public health.“